Structure-activity relationships in 2-aminodiphenylsulfides against trypanothione reductase from Trypanosoma cruzi

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 10, 1998, Pages 1175-1180

  Girault, Sophie ^a   Davioud Charvet, Elisabeth ^a   Salmon, Laurence ^a   Berecibar, Amaya ^a   Debreu, Marie Ange ^a   Sergheraert, Christian ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENOL DERIVATIVE; ANTIPROTOZOAL AGENT; PHENOTHIAZINE DERIVATIVE;

ARTICLE; CHAGAS DISEASE; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA CRUZI;

ANIMALS; DRUG DESIGN; ENZYME INHIBITORS; INDICATORS AND REAGENTS; KINETICS; MOLECULAR STRUCTURE; NADH, NADPH OXIDOREDUCTASES; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0032546512     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00180-2     Document Type: Article

References (26)

1. 1. Chagas disease, WHO, technical reports 1991, 811
2. 2. Rodriguez, J.B.; Cros, E.G. Current Med. Chem. 1995, 2, 723.
3. 3. Fairlamb, A.H.; Blackburn, P.; Ulrich, P.; Chait, B.T.; Cerami, A. Science 1985, 27, 1485.
4. 4. Fairlamb, A.H.; Cerami, A. Mol. Biochem. Parasitol. 1985, 14, 187.
5. 5. Fairlamb, A.H.; Cerami, A. Annu. Rev. Microbiol. 1992, 46, 695.
6. 6. Henderson, G.B.; Fairlamb, A.H.; Ulrich, P.; Cerami, A. Biochemistry 1987, 26, 3023.
7. 7. Aumercier, M.; Mezziane-Cherif, D.; Moutiez, M.; Tartar, A.; Sergheraert, C. Bioorg. Med. Chem. Lett. 1994, 223, 161.
8. 8. Fernandez-Gomez, R.; Moutiez, M.; Aumercier, M.; Tartar, A.; Sergheraert, C. Int. J. Antimicrob. Agents 1995, 6, 111.
9. 9. Baillet, S.; Buisine, E.; Horvath, D.; Maes, L.; Bonnet, B.; Sergheraert C. Bioorg. Med. Chem. 1996, 4, 891.
10. 10. Kuriyan, J.; Kong, X.P.; Krishna, T.S.R.; Sweet, R.M.; Murgolo, N.J.; Field, H.; Cerami, A.; Henderson, G.B. Proc. Natl. Acad. Sci. USA 1991, 88, 8764.
11. 11. Girault, S.; Baillet, S.; Horvath, D.; Lucas, V.; Davioud-Charvet, E.; Tartar, A.; Sergheraert, C. Eur. J. Med. Chem. 1997, 32, 39.
12. 12. Schirmer, R.H.; Schöllhammer, T.; Eisenbrand, G.; Krauth-Siegel, R.L. Free Rad. Res. Commun. 1987, 3, 3.
13. 13. Henderson, G.B.; Ulrich, P.; Fairlamb, A.H.; Rosenberg, I.; Pereira, M.; Sela, M.; Cerami, A. Proc. Natl. Acad. Sci. USA 1988, 85, 5374.
14. 14. Jockers-Scherübl, M.C.; Schirmer, R.H.; Krauth-Siegel, R.L. Eur. J. Biochem. 1989, 180, 267.
15. 15. Cenas, N.; Bironaite, D.; Dickancaite, E.; Anusevicius, Z.; Sarlauskas, J.; Blanchard, J.S. Biochem. Biophys. Res. Commun. 1994, 204, 224.
16. 16. Cenas, N.; Arscott, D.; Williams, C.H.; Blanchard, J.S. Biochemistry 1994, 33, 2509.
17. 1H NMR and MS consistent with their structure and elemental analytical data were satisfactory.
18. 18. Sharma, H.L.; Sharma, V.N.; Mital, R.L. Tetrahedron Lett. 1967, 17, 1657.
19. 19. Kaestle, K.L.; Anwer, M.K.; Audhya, T.K.; Goldstein, G. Tetrahedron Lett. 1991, 32, 327.
20. 20. Coste, J.; Frérot, E.; Jouin, P. J. Org. Chem. 1994, 59, 2437.
21. 21. Kokotos, G.; Noula, C. J. Org. Chem. 1996, 61, 6994.
22. 22. Ohta, S.; Hinata, Y.; Yamashita, M.; Kawasaki, I.; Shoji, T.; Yoshikawa, H.; Obana, Y. Chem. Pharm. Bull. 1994, 42, 1185.
23. 23. 1 eq. DCC, 3 eq. DMAP, THF, rt, 24h.
24. 50 were measured with the oxalate salts of the different synthesized compounds.
25. -1) and by measuring absorbance changes in the absence or in the presence of superoxide dismutase (0.5 units in 120 μl-cuve).
26. 26. Lin, A.J.; Sartorelli, A.C. Biochem. Pharmacol. 1976, 25, 206.